SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 14th, 2018 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research • California
This Registration Rights Agreement (this “Agreement”) is made as of June 13, 2018, by and among Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers identified on Schedule A hereto (each, a “Purchaser” and collectively, the “Purchasers”) and such other Persons, if any, from time to time, that become a party hereto as holders of Registrable Securities (as defined below). Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in that certain Securities Purchase Agreement dated as of March 26, 2018 by and among the Company and the Purchasers (as may be amended or restated from time to time, the “Purchase Agreement”).
Amendment No. 1 to Securities PURCHASE AGREEMENTSecurities Purchase Agreement • June 14th, 2018 • Sorrento Therapeutics, Inc. • Services-commercial physical & biological research
This Amendment No. 1 to Securities Purchase Agreement (this “Amendment”) is effective as of June 13, 2018 by and among Sorrento Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages to this Amendment (collectively, the “Majority Purchasers”).
